Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases

Hyunji Lee,Seonghyun Lee,Gayoung Baek,Annie Kim,Beum-Chang Kang,Huiyun Seo,Jin-Soo Kim
DOI: https://doi.org/10.1038/s41467-021-21464-1
IF: 16.6
2021-02-19
Nature Communications
Abstract:Abstract DddA-derived cytosine base editors (DdCBEs), composed of the split interbacterial toxin DddA tox , transcription activator-like effector (TALE), and uracil glycosylase inhibitor (UGI), enable targeted C-to-T base conversions in mitochondrial DNA (mtDNA). Here, we demonstrate highly efficient mtDNA editing in mouse embryos using custom-designed DdCBEs. We target the mitochondrial gene, MT-ND5 ( ND5 ), which encodes a subunit of NADH dehydrogenase that catalyzes NADH dehydration and electron transfer to ubiquinone, to obtain several mtDNA mutations, including m.G12918A associated with human mitochondrial diseases and m.C12336T that incorporates a premature stop codon, creating mitochondrial disease models in mice and demonstrating a potential for the treatment of mitochondrial disorders.
multidisciplinary sciences
What problem does this paper attempt to address?